Back to Search Start Over

Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome.

Authors :
Verkouteren BJ
Roemen GM
Schuurs-Hoeijmakers JH
Abdul Hamid M
van Geel M
Speel EM
Mosterd K
Source :
Journal of clinical pathology [J Clin Pathol] 2023 May; Vol. 76 (5), pp. 345-348. Date of Electronic Publication: 2022 Aug 24.
Publication Year :
2023

Abstract

Basal cell nevus syndrome (BCNS) is a rare genetic disorder accompanied by a broad variety of tumours, of which basal cell carcinomas and odontogenic keratocysts are the most common. BCNS is caused by a germline or postzygotic mutation in either PTCH1 or SUFU As BCNS is a rare disease, it is difficult to establish whether less frequently occurring tumours are actually part of the syndrome. In this study, the molecular mechanism behind four extracutaneous tumours in patients with BCNS was elucidated. A leiomyoma of the testis and meningioma were confirmed to be associated with BCNS in two patients by presence of a second mutation or loss of heterozygosity in PTCH1 In a meningioma of a patient with a mosaic postzygotic PTCH1 mutation an association could not be conclusively confirmed. SUFU was probably not involved in the development of a thyroid carcinoma in a patient with a germline SUFU mutation. Hence, we have proven that meningioma and leiomyoma of the testis are rare extracutaneous tumours that are part of BCNS.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
1472-4146
Volume :
76
Issue :
5
Database :
MEDLINE
Journal :
Journal of clinical pathology
Publication Type :
Academic Journal
Accession number :
36002246
Full Text :
https://doi.org/10.1136/jcp-2022-208391